The SSAC Meeting Scientific Programme 2009

The SSAC (Scandinavian Society for Antimicrobial Chemotherapy) 26th Annual Meeting 

3–6 September 2009.

Tromsø Norway.

 

Thursday 03.09.2009

SSAC Board meeting (12.00 – 15.00) 
On board the coastal steamer from Bodø to Tromsø

Pk/Pd in bacterial infections
Afternoon minicourse (15.00 - 19.00)
Chair: Niels Frimodt-Møller (DK) and Truls Leegard (NO)

1.    Pharmacokinetics of antibiotics, Rolf Walstad, Trondheim (NO)
2.    Pk/Pd of antibiotics in vitro, Inga Odenholt, Malmø (SE)
3.    Pk/Pd of antibiotics in vivo, Jenny Dahl Knudsen, København (DK)
4.    Antibiotic dosing in children – clinical use of Pk/Pd principles, Heikki Peltola, Helsinki (FI) 
5.    Pk/Pd and prevention of resistance, Klaus Skovbo Jensen, København (DK)
6.    Practical examples and discussion, Niels Frimodt – Møller, København (DK) and Truls Leegaard, Oslo (NO)

Friday 04.09.2009

Trends in Gram negative resistance - where are we heading?

Wyeth satellite symposium (08.30 – 11.00)

Chair: Gunnar Kahlmeter (SE) and Arnfinn Sundsfjord (NO)

1.    The clones are attacking: bacterial knock-out on current antimicrobial agents, Christian Giske, Stockholm (SE)
2.    Treatment of ESBL infections from a Nordic point of view, Asko Järvinen, Helsinki (FI)
3.    MDR, XDR, and PDR Gram-negative bacterial infections: a global threat, Matthew Falagas, Athens (GR) and Boston (US)
4.    Multi Drug Resistant Gram negatives and infection prevention, Egil Lingås, Oslo (NO)

Registration, posters and exhibition (11.00 – 12.00)

Lunch (12.00 – 13.00)

Opening ceremony (13.00 – 13.15)

Niels Frimodt-Møller (Chairman of SSAC) and Arnfinn Sundsfjord (Congress President)

Management of HIV infections - diagnostic and therapeutic approaches to HIV resistance Symposium (13.15 – 15.00)

Chair: Lars Østergaard (DK) and Johan Bruun (NO)

1.    Introduction: Resistance to antiretroviral drugs in the Nordic countries, Vidar Ormaasen, Oslo (NO)
2.    How to use new antiretroviral drug classes, Magnus Gisslén, Gothenburg (SE) 
3.    Use of genotypic resistance testing for selection of drug regimens for experienced[bek2.1] patients with virological failure, Anders Sønnerborg, Stockholm (SE)
4.    Laboratory surveillance for side effects of ART. When and how should therapy be changed? Nina Friis-Møller, Copenhagen (DK)

Posters and exhibition (15.00 – 15.45)

Invited young scientists

Symposium (15.45 – 17.30)

Chair: Bjørn Erik Kristiansen (NO) and Marianne Jertborn (SE)

1.    Evaluation of wild-type MIC-distributions as a tool in the determination of clinical breakpoints in Mycobacterium tuberculosis, Thomas Schöm, Kalmar (SE

2.    Emergence of carbapenemase-producing multi-drug resistant Gram-negative bacteria, Ørjan Samuelsen, Tromsø (NO)

3.    Pneumonia among individuals with HIV - the impact of HAART, Ole K. Søgaard, Århus (DK)

4.    HIV outbreak among injecting drug users in Finland, Pia Kivela, Helsinki (FI)

Late breaker session (17.30 – 18.00)
Chair: Trond Flægstad (NO)

 

Saturday 05.09.2009

Staphylococcus aureus - the balance between commensalism and pathogenicity; clinical treatment of infections, resistance, infection control, population biology, colonization, infection control, host biology

Symposium (08.30 – 10.30)

Chair: Robert Skov (DK) and Claus Ola Solberg (NO) 

1.    Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus, Alex van Belkum, Rotterdam (NL)
2.    Staphylococcus aureus: A Well-Armed Pathogen, Elisabet Josefsson, Göteborg (SE)
3.    Innate immunity and infectious disease susceptibility (title not confirmed), Peter Garred, Copenhagen (DK)
4.    Updates on treatment of Staphylococcus aureus / MRSA , Paul Tulkens, Brussels (BE)

Posters and exhibition (10.30 – 11.15)

Honorary lecture (11.15 – 12.00)
Introduction: Claus Ola Solberg (NO) and Arnfinn Sundsfjord (NO)

Lunch (12.00 – 13.00)

Lower respiratory tract infections - clinical management in the era of novel diagnostic tools Symposium (13.00 – 15.00)

Chair: Terho Heikkinen (FI) and Karl Kristinsson (IS)

1.    Diagnostic methods for bacterial etiology in adult community-acquired pneumonia, Hans Holmberg, Ørebro (SE)
2.    Diagnosis and treatment of LRI in young children. Clinical relevance of viral quantification, Svein Arne Norbø, Trondheim (NO) and Henrik Døllner, Trondheim (NO)
3.    Use of modern molecular biology to study and understand the host’s immune response to RSV infection, Hans Olav Fjærli, Lørenskog (NO)
4.    Respiratory infections in the immunocompromised host, Britt-Marie Eriksson, Uppsala (SE)

Posters and exhibition (15.00 – 15.45)

Free oral presentations (15.45 – 17.30)

Chair: Jenny Dahl Knudsen (DK) and Olav Øktedalen (NO)

Poster awards (17.30 – 18.00)
Nominated by SSAC Board members.

 

Sunday 06.09.2009

SSAC Annual General Meeting (08.30 – 09.15)

Interactive session in clinical microbiology and infectious diseases (09.15 – 10.15)
Chair: Vegard Skogen, Tromsø (NO) and Gunnar Skov Simonsen, Tromsø (NO)

Posters and exhibition (10.15 – 10.45)

Best recent papers (10.45 – 12.00)
Chair: Ann Søderstrøm (SE) and Bodil Erikséen Neumann (FI)

1.    Clinical infectious diseases, Henrik Nielsen, Aalborg (DK)

2.    Virology, Timo Vesikari, Tampere (FI)

3.    Travel and tropical medicine, Mogens Jensenius, Oslo (NO)

4.    Infection control in enteric diseases, Christina Åhrén, Gøteborg (SE)

5.    Fungal infections, Ingibjörg Hilmarsdóttir, Reykjavik (IS)

Lunch 12.00 - 13.00